HealthEquity's HSAnswers tool wins multiple awards for AI-driven benefits education, enhancing consumer access to HSA information.
Quiver AI Summary
HealthEquity, Inc. has announced that its AI-powered educational tool, HSAnswers, has won several notable industry awards for its innovative approach to benefits education. Launched in October 2024, HSAnswers utilizes generative AI to quickly and reliably answer questions regarding Health Savings Accounts (HSAs) and other consumer-directed benefits. The platform has received accolades including the 2025 AI Breakthrough Awards and the Globee Silver Winner Awards. With a strong emphasis on addressing real-world inquiries that healthcare consumers have, HSAnswers has engaged in hundreds of thousands of conversations, highlighting the demand for better benefits education among employees. HealthEquity aims to further develop HSAnswers by expanding its capabilities and providing valuable resources to a wide audience, including current and prospective members and benefits administrators.
Potential Positives
- HealthEquity's HSAnswers has received multiple prestigious awards, establishing its leadership in AI-powered benefits education innovation.
- The tool has facilitated hundreds of thousands of conversations, addressing a critical marketplace need for improved benefits education among healthcare consumers.
- HSAnswers is freely available to a wide audience, expanding the company's reach and potential user engagement, thus enhancing brand visibility and reputation.
Potential Negatives
- While the press release highlights the awards received by HSAnswers, it does not provide specific metrics or data on the user engagement or satisfaction with the tool, which may lead to questions about its actual effectiveness.
- The announcement primarily focuses on accolades rather than addressing any potential limitations, challenges, or customer feedback related to HSAnswers, which could be perceived as a lack of transparency.
FAQ
What is HSAnswers?
HSAnswers is an AI-powered educational tool by HealthEquity that provides quick, reliable answers to HSA and consumer-directed benefit questions.
What awards has HSAnswers won?
HSAnswers has received several awards including the 2025 AI Breakthrough Awards and two Globee Silver Awards for AI achievement.
How does HSAnswers improve benefits education?
HSAnswers simplifies complex healthcare information, delivering personalized insights and answers to help consumers understand their benefits better.
Who can use HSAnswers?
HSAnswers is freely available to everyone, including HealthEquity members, benefits administrators, brokers, consultants, and health plan partners.
How can I access HSAnswers?
You can start using HSAnswers by visiting https://www.healthequity.com/hsanswers and asking your questions online.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$HQY Congressional Stock Trading
Members of Congress have traded $HQY stock 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $HQY stock by members of Congress over the last 6 months:
- REPRESENTATIVE LISA C. MCCLAIN has traded it 2 times. They made 1 purchase worth up to $15,000 on 06/11 and 1 sale worth up to $15,000 on 06/17.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. sold up to $15,000 on 06/16.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$HQY Insider Trading Activity
$HQY insiders have traded $HQY stock on the open market 17 times in the past 6 months. Of those trades, 0 have been purchases and 17 have been sales.
Here’s a breakdown of recent trading of $HQY stock by insiders over the last 6 months:
- JON KESSLER has made 0 purchases and 9 sales selling 231,950 shares for an estimated $25,992,976.
- ELIMELECH ROSNER (EVP, CHIEF TECHNOLOGY OFFICER) has made 0 purchases and 2 sales selling 71,000 shares for an estimated $7,976,299.
- MICHAEL HENRY FIORE (EVP, CHIEF COMMERCIAL OFFICER) has made 0 purchases and 3 sales selling 10,675 shares for an estimated $877,544.
- ROBERT W SELANDER has made 0 purchases and 3 sales selling 5,750 shares for an estimated $446,512.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$HQY Hedge Fund Activity
We have seen 249 institutional investors add shares of $HQY stock to their portfolio, and 271 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WEALTHFRONT ADVISERS LLC removed 107,390,188 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $9,490,070,913
- WASATCH ADVISORS LP removed 1,132,972 shares (-15.7%) from their portfolio in Q2 2025, for an estimated $118,690,146
- VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. removed 835,413 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $87,517,865
- CITADEL ADVISORS LLC added 777,148 shares (+179.4%) to their portfolio in Q2 2025, for an estimated $81,414,024
- WESTFIELD CAPITAL MANAGEMENT CO LP added 701,819 shares (+124.6%) to their portfolio in Q2 2025, for an estimated $73,522,558
- ATALAN CAPITAL PARTNERS, LP added 700,000 shares (+inf%) to their portfolio in Q2 2025, for an estimated $73,332,000
- AQR CAPITAL MANAGEMENT LLC added 661,795 shares (+148.5%) to their portfolio in Q2 2025, for an estimated $69,329,644
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$HQY Analyst Ratings
Wall Street analysts have issued reports on $HQY in the last several months. We have seen 7 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Barrington Research issued a "Outperform" rating on 08/29/2025
- RBC Capital issued a "Outperform" rating on 08/28/2025
- Deutsche Bank issued a "Buy" rating on 06/05/2025
- B of A Securities issued a "Buy" rating on 06/04/2025
- JMP Securities issued a "Market Outperform" rating on 06/04/2025
- Keybanc issued a "Overweight" rating on 04/16/2025
- Raymond James issued a "Strong Buy" rating on 03/25/2025
To track analyst ratings and price targets for $HQY, check out Quiver Quantitative's $HQY forecast page.
$HQY Price Targets
Multiple analysts have issued price targets for $HQY recently. We have seen 9 analysts offer price targets for $HQY in the last 6 months, with a median target of $117.0.
Here are some recent targets:
- Alexander Paris from Barrington Research set a target price of $125.0 on 08/29/2025
- Daniel R. Perlin from RBC Capital set a target price of $109.0 on 08/28/2025
- C. Gregory Peters from Raymond James set a target price of $120.0 on 07/08/2025
- George Hill from Deutsche Bank set a target price of $115.0 on 06/05/2025
- Constantine Davides from JMP Securities set a target price of $117.0 on 06/04/2025
- Allen Lutz from B of A Securities set a target price of $125.0 on 06/04/2025
- David Roman from Goldman Sachs set a target price of $104.0 on 06/04/2025
Full Release
DRAPER, Utah, Aug. 29, 2025 (GLOBE NEWSWIRE) -- HealthEquity , Inc. (Nasdaq: HQY), the nation’s largest Health Savings Accounts (HSAs) and consumer-directed benefits administrator, today announced that its innovative AI-powered educational tool, HSAnswers , has received multiple prestigious industry awards recognizing its excellence in artificial intelligence and benefits education innovation.
HSAnswers is designed to provide fast and reliable responses to HSAs questions and other consumer-directed benefits (CDBs). The tool uses generative artificial intelligence to deliver personalized conversation and insights powered by HealthEquity's comprehensive knowledge base and industry expertise.
Since its launch in October 2024, HSAnswers has garnered industry recognition, including the 2025 AI Breakthrough Awards for Informational Bot Solution of the Year; 2025 Globee Silver Winner for Artificial Intelligence Achievement of the Year; and 2025 Globee Silver Winner for AI-based Solution for Healthcare. These accolades highlight HSAnswers' groundbreaking approach to making complex healthcare benefits more accessible and understandable for millions of Americans.
Advanced Technology Meets Real-World Impact
HSAnswers has already demonstrated remarkable impact since its launch, facilitating hundreds of thousands of conversations. The platform addresses real-world questions that matter to healthcare consumers, from practical inquiries like "Can I use my HSA to pay for teeth aligners?" to complex scenarios such as "I am turning 65 at the end of the year and will be signing up for Medicare for 2026—am I able to contribute to my HSA account this year through 2025?" This sustained engagement reflects the tool's ability to provide meaningful guidance that addresses a critical marketplace need, where 73% of
employees express demand for improved benefits education
.
“While the marketplace floods with generic AI tools, HSAnswers distinguishes itself through its deep expertise in consumer-directed benefits and ability to simplify complexity by providing instant, personalized answers without requiring users to navigate through extensive documentation," said Shuki Licht, HealthEquity Head of Innovation and VP of AI Tech. "When employees spend just 30 minutes or less reviewing benefits during enrollment, they're inevitably left with questions. We're leveraging AI to solve real problems impacting millions of Americans' healthcare decisions, continuing to elevate our members’ experiences and delivering answers efficiently at scale when people need them most.”
Transforming Benefits Education Through AI Innovation
The tool leverages over 500 curated HealthEquity educational resources and its comprehensive knowledge base powered by more than 20 years of industry expertise and leadership, those that query HSAnswers can depend on its reliable and contextually relevant information about HSAs and other CDBs including FSAs, HRAs, and LSAs. The company continues investing in the tool and aims to include even more sophisticated use cases to elevate member experiences in the coming months.
HSAnswers is freely available to anyone at healthequity.com/hsanswers including current and prospective HealthEquity members, benefits administrators, brokers, consultants, and health plan partners. Start asking questions now at https://www.healthequity.com/hsanswers .
About HealthEquity
HealthEquity and its subsidiaries administer HSAs and other consumer-directed benefits for more than 17 million accounts in partnership with employers, benefits advisors, and health and retirement plan providers who share our mission to save and improve lives by empowering healthcare consumers. For more information, visit
www.healthequity.com.
Media Contact
Atiya Easterling
[email protected]
